免疫系における重要な転写因子NF-κBの阻害剤

文献

• 1)Inducibility of κ immunoglobulin enhancer-binding protein NF-κB by a posttranslational mechanism
  • R. Sen, D. Baltimore, Cell 1986, 47, 921.
• 2)The complexity of NF-κB signaling in inflammation and cancer
  • B. Hoesel, J. A Schmid, Mol. Cancer 2013, 12, 86.
• 3)Novel inhibitors of cytokine-induced IκBα phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo
  • J. W. Pierce, R. Schoenleber, G. Jesmok, J. Best, S. A. Moore, T. Collins, M. E. Gerritsen, J. Biol. Chem. 1997, 272, 21096.
• 4)Bay 11-7082 inhibits transcription factor NF-κB and induces apoptosis of HTLV-I–infected T-cell lines andκprimary adult T-cell leukemia cells
  • N. Mori, Y. Yamada, S. Ikeda, Y. Yamasaki, K. Tsukasaki, Y. Tanaka, M. Tomonaga, N. Yamamoto, M. Fujii, Blood 2002, 100, 1828.
• 5)Nuclear factor-κB inhibitors as sensitizers to anticancer drugs
  • C. Nakanishi, M. Toi, Nat. Rev. Cancer 2005, 5, 297.
• 6)Anti-inflammatory compounds parthenolide and Bay 11-7082 are direct inhibitors of the inflammasome
  • C. Juliana, T. Fernandes-Alnemri, J. Wu, P. Datta, L. Solorzano, J.-W. Yu, R. Meng, A. A. Quong, E. Latz, C. P. Scott, E. S. Alnemri, J. Biol. Chem. 2010, 285, 9792.
• 7)The effects of heat shock protein 90 inhibitors on apoptosis and viral replication in primary effusion lymphoma cells
  • C. Higashi, C. Saji, K. Yamada, H. Kagawa, R. Ohga, T. Taira, M. Fujimuro, Biol. Pharm. Bull. 2012, 35, 725.

ページトップへ